Soleno TherapeuticsSLNO
那斯達克 · USD
49.49
-0.51
(-1.02%)
收盤 12/12 04:59 (UTC+8)
盤後
49.22
49.22
(-0.55%)
12/12 04:59 (UTC+8)
Soleno TherapeuticsSLNO
49.49
-0.51
(-1.02%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- 0.33
- 0.66
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 102.16
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 66,018 | 32,657 | - | - | - | - | - | - | - | - |
營業成本 | 1,141 | 696 | - | - | - | - | - | - | - | - |
營業毛利 | 64,877 | 31,961 | - | - | - | - | - | - | - | - |
營業費用 | 42,772 | 38,486 | 45,743 | 59,116 | 80,212 | - | - | 13,910 | 10,382 | 8,623 |
研發費用 | 8,405 | 9,147 | 13,517 | 21,486 | 30,138 | 12,342 | 14,602 | 8,689 | 6,043 | 5,141 |
推銷及管理費用 | 34,367 | 29,339 | 32,226 | 37,630 | 50,074 | 12,526 | 8,873 | 5,221 | 4,339 | 3,482 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 22,105 | -6,525 | -45,743 | -59,116 | -80,212 | -24,868 | -23,475 | -13,910 | -10,382 | -8,623 |
其他收入及費用 | 5,298 | 3,193 | 3,331 | 3,365 | 3,596 | 3,014 | 2,077 | 2,614 | -479 | 148 |
利息費用 | 1,390 | 1,376 | 1,361 | 231 | - | - | - | - | - | - |
稅前純益 | 26,013 | -4,708 | -43,773 | -55,982 | -76,616 | -21,854 | -21,398 | -11,296 | -10,861 | -8,475 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | 26,013 | -4,708 | -43,773 | -55,982 | -76,616 | -21,854 | -21,398 | -11,296 | -10,861 | -8,475 |
基本每股稅後盈餘(元) | 0.49 | -0.09 | -0.95 | -1.27 | -1.83 | -0.57 | -0.59 | - | -0.95 | -0.81 |
稀釋每股稅後盈餘(元) | 0.55 | -0.05 | -0.95 | -1.30 | -1.92 | -0.57 | -0.59 | 0.29 | -0.96 | -0.81 |
基本平均股數(千股) | 53328.00 | 50483.00 | 46178.00 | 43924.00 | 41879.00 | 38631.00 | 36208.00 | - | 11436.00 | 10423.00 |
稀釋平均股數(千股) | 54921.00 | 50483.00 | 46178.00 | 43924.00 | 41879.00 | 38631.00 | 36208.00 | - | 11436.00 | 10423.00 |
還原基本每股稅後盈餘(元) | 0.49 | -0.09 | -0.95 | -1.27 | -1.83 | -0.57 | -0.59 | - | -0.95 | -0.81 |
還原稀釋每股稅後盈餘(元) | 0.55 | -0.05 | -0.95 | -1.30 | -1.92 | -0.57 | -0.59 | 0.29 | -0.96 | -0.81 |
還原基本平均股數(千股) | 53,328 | 50,483 | 46,178 | 43,924 | 41,879 | 38,631 | 36,208 | - | 11,436 | 10,423 |
還原稀釋平均股數(千股) | 54,921 | 50,483 | 46,178 | 43,924 | 41,879 | 38,631 | 36,208 | - | 11,436 | 10,423 |
EBITDA(千元) | 27,543 | -3,795 | -42,880 | -56,648 | -78,025 | -22,473 | -21,381 | -10,807 | -10,371 | -7,986 |